User menu

Low Concordance between Gene Expression Signatures in ER Positive HER2 Negative Breast Carcinoma Could Impair Their Clinical Application

Bibliographic reference Laas, Enora ; Mallon, Peter ; Duhoux, François ; Hamidouche, Amina ; Rouzier, Roman ; et. al. Low Concordance between Gene Expression Signatures in ER Positive HER2 Negative Breast Carcinoma Could Impair Their Clinical Application. In: PLoS One, Vol. 11, no.2, p. e0148957 (2016)
Permanent URL http://hdl.handle.net/2078.1/186099
  1. Goldhirsch A., Wood W. C., Coates A. S., Gelber R. D., Thurlimann B., Senn H.- J., , Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011, 10.1093/annonc/mdr304
  2. National Comprehensive Cancer Network [Internet]. Available: https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.
  3. Paik Soonmyung, Shak Steven, Tang Gong, Kim Chungyeul, Baker Joffre, Cronin Maureen, Baehner Frederick L., Walker Michael G., Watson Drew, Park Taesung, Hiller William, Fisher Edwin R., Wickerham D. Lawrence, Bryant John, Wolmark Norman, A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer, 10.1056/nejmoa041588
  4. Paik Soonmyung, Tang Gong, Shak Steven, Kim Chungyeul, Baker Joffre, Kim Wanseop, Cronin Maureen, Baehner Frederick L., Watson Drew, Bryant John, Costantino Joseph P., Geyer Charles E., Wickerham D. Lawrence, Wolmark Norman, Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer, 10.1200/jco.2005.04.7985
  5. Albain Kathy S, Barlow William E, Shak Steven, Hortobagyi Gabriel N, Livingston Robert B, Yeh I-Tien, Ravdin Peter, Bugarini Roberto, Baehner Frederick L, Davidson Nancy E, Sledge George W, Winer Eric P, Hudis Clifford, Ingle James N, Perez Edith A, Pritchard Kathleen I, Shepherd Lois, Gralow Julie R, Yoshizawa Carl, Allred D Craig, Osborne C Kent, Hayes Daniel F, Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial, 10.1016/s1470-2045(09)70314-6
  6. van de Vijver Marc J., He Yudong D., van 't Veer Laura J., Dai Hongyue, Hart Augustinus A.M., Voskuil Dorien W., Schreiber George J., Peterse Johannes L., Roberts Chris, Marton Matthew J., Parrish Mark, Atsma Douwe, Witteveen Anke, Glas Annuska, Delahaye Leonie, van der Velde Tony, Bartelink Harry, Rodenhuis Sjoerd, Rutgers Emiel T., Friend Stephen H., Bernards René, A Gene-Expression Signature as a Predictor of Survival in Breast Cancer, 10.1056/nejmoa021967
  7. van 't Veer Laura J., Dai Hongyue, van de Vijver Marc J., He Yudong D., Hart Augustinus A. M., Mao Mao, Peterse Hans L., van der Kooy Karin, Marton Matthew J., Witteveen Anke T., Schreiber George J., Kerkhoven Ron M., Roberts Chris, Linsley Peter S., Bernards René, Friend Stephen H., Gene expression profiling predicts clinical outcome of breast cancer, 10.1038/415530a
  8. WANG Y, KLIJN J, ZHANG Y, SIEUWERTS A, LOOK M, YANG F, TALANTOV D, TIMMERMANS M, MEIJERVANGELDER M, YU J, Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer, 10.1016/s0140-6736(05)70933-8
  9. Desmedt C., Piette F., Loi S., Wang Y., Lallemand F., Haibe-Kains B., Viale G., Delorenzi M., Zhang Y., d'Assignies M. S., Bergh J., Lidereau R., Ellis P., Harris A. L., Klijn J. G.M., Foekens J. A., Cardoso F., Piccart M. J., Buyse M., Sotiriou C., , Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series, 10.1158/1078-0432.ccr-06-2765
  10. Teschendorff Andrew E, Miremadi Ahmad, Pinder Sarah E, Ellis Ian O, Caldas Carlos, An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer, 10.1186/gb-2007-8-8-r157
  11. Carter Scott L, Eklund Aron C, Kohane Isaac S, Harris Lyndsay N, Szallasi Zoltan, A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers, 10.1038/ng1861
  12. Chang H. Y., Nuyten D. S. A., Sneddon J. B., Hastie T., Tibshirani R., Sorlie T., Dai H., He Y. D., van't Veer L. J., Bartelink H., van de Rijn M., Brown P. O., van de Vijver M. J., From The Cover: Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival, 10.1073/pnas.0409462102
  13. Liu Rui, Wang Xinhao, Chen Grace Y., Dalerba Piero, Gurney Austin, Hoey Timothy, Sherlock Gavin, Lewicki John, Shedden Kerby, Clarke Michael F., The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells, 10.1056/nejmoa063994
  14. Sotiriou Christos, Wirapati Pratyaksha, Loi Sherene, Harris Adrian, Fox Steve, Smeds Johanna, Nordgren Hans, Farmer Pierre, Praz Viviane, Haibe-Kains Benjamin, Desmedt Christine, Larsimont Denis, Cardoso Fatima, Peterse Hans, Nuyten Dimitry, Buyse Marc, Van de Vijver Marc J., Bergh Jonas, Piccart Martine, Delorenzi Mauro, Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis, 10.1093/jnci/djj052
  15. Wirapati Pratyaksha, Sotiriou Christos, Kunkel Susanne, Farmer Pierre, Pradervand Sylvain, Haibe-Kains Benjamin, Desmedt Christine, Ignatiadis Michail, Sengstag Thierry, Schütz Frédéric, Goldstein Darlene R, Piccart Martine, Delorenzi Mauro, Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures, 10.1186/bcr2124
  16. Barry William T., Kernagis Dawn N., Dressman Holly K., Griffis Ryan J., Hunter J'Vonne D., Olson John A., Marks Jeff R., Ginsburg Geoffrey S., Marcom Paul K., Nevins Joseph R., Geradts Joseph, Datto Michael B., Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome, 10.1200/jco.2009.26.7245
  17. Haury A-C, Jacob L, Vert J-P. Increasing stability and interpretability of gene expression signatures. ArXiv Prepr ArXiv10013109. 2010; Available: http://arxiv.org/abs/1001.3109.
  18. Michiels Stefan, Koscielny Serge, Hill Catherine, Prediction of cancer outcome with microarrays: a multiple random validation strategy, 10.1016/s0140-6736(05)17866-0
  19. Ein-Dor L., Kela I., Getz G., Givol D., Domany E., Outcome signature genes in breast cancer: is there a unique set?, 10.1093/bioinformatics/bth469
  20. Reyal Fabien, van Vliet Martin H, Armstrong Nicola J, Horlings Hugo M, de Visser Karin E, Kok Marlen, Teschendorff Andrew E, Mook Stella, van 't Veer Laura, Caldas Carlos, Salmon Remy J, Vijver Marc J van de, Wessels Lodewyk FA, A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer, 10.1186/bcr2192
  21. Engelhardt Ellen G., Garvelink Mirjam M., de Haes J. (Hanneke) C.J.M., van der Hoeven Jacobus J.M., Smets Ellen M.A., Pieterse Arwen H., Stiggelbout Anne M., Predicting and Communicating the Risk of Recurrence and Death in Women With Early-Stage Breast Cancer: A Systematic Review of Risk Prediction Models, 10.1200/jco.2013.50.3417
  22. Loi Sherene, Haibe-Kains Benjamin, Desmedt Christine, Lallemand Françoise, Tutt Andrew M., Gillet Cheryl, Ellis Paul, Harris Adrian, Bergh Jonas, Foekens John A., Klijn Jan G.M., Larsimont Denis, Buyse Marc, Bontempi Gianluca, Delorenzi Mauro, Piccart Martine J., Sotiriou Christos, Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade, 10.1200/jco.2006.07.1522
  23. Miller L. D., Smeds J., George J., Vega V. B., Vergara L., Ploner A., Pawitan Y., Hall P., Klaar S., Liu E. T., Bergh J., From The Cover: An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival, 10.1073/pnas.0506230102
  24. Minn Andy J., Gupta Gaorav P., Siegel Peter M., Bos Paula D., Shu Weiping, Giri Dilip D., Viale Agnes, Olshen Adam B., Gerald William L., Massagué Joan, Genes that mediate breast cancer metastasis to lung, 10.1038/nature03799
  25. Pawitan Yudi, Bjöhle Judith, Amler Lukas, Borg Anna-Lena, Egyhazi Suzanne, Hall Per, Han Xia, Holmberg Lars, Huang Fei, Klaar Sigrid, Liu Edison T, Miller Lance, Nordgren Hans, Ploner Alexander, Sandelin Kerstin, Shaw Peter M, Smeds Johanna, Skoog Lambert, Wedrén Sara, Bergh Jonas, Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts, 10.1186/bcr1325
  26. Chin Koei, DeVries Sandy, Fridlyand Jane, Spellman Paul T., Roydasgupta Ritu, Kuo Wen-Lin, Lapuk Anna, Neve Richard M., Qian Zuwei, Ryder Tom, Chen Fanqing, Feiler Heidi, Tokuyasu Taku, Kingsley Chris, Dairkee Shanaz, Meng Zhenhang, Chew Karen, Pinkel Daniel, Jain Ajay, Ljung Britt Marie, Esserman Laura, Albertson Donna G., Waldman Frederic M., Gray Joe W., Genomic and transcriptional aberrations linked to breast cancer pathophysiologies, 10.1016/j.ccr.2006.10.009
  27. Gene Expression Omnibus [Internet]. Available: http://www.ncbi.nlm.nih.gov/geo/.
  28. ArrayExpress repository [Internet]. Available: http://www.ebi.ac.uk/microarray-as/ae/.
  29. R [Internet]. Available: http://bioconductor.wustl.edu/bioc/html/affyPLM.html.
  30. Bioconductor [Internet]. Available: http://www.bioconductor.org.
  31. Gong Yun, Yan Kai, Lin Feng, Anderson Keith, Sotiriou Christos, Andre Fabrice, Holmes Frankie A, Valero Vicente, Booser Daniel, Pippen John E, Vukelja Svetislava, Gomez Henry, Mejia Jaime, Barajas Luis J, Hess Kenneth R, Sneige Nour, Hortobagyi Gabriel N, Pusztai Lajos, Symmans W Fraser, Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study, 10.1016/s1470-2045(07)70042-6
  32. Haybittle J L, Blamey R W, Elston C W, Johnson J, Doyle P J, Campbell F C, Nicholson R I, Griffiths K, A prognostic index in primary breast cancer, 10.1038/bjc.1982.62
  33. RW Blamey, Eur J Cancer Oxf Engl 1990, 43, 1548 (2007)
  34. Comment on the Nottingham Prognostic Index, 10.1007/bf00689843
  35. Balslev Ingegerd, Axelsson Christen Kirk, Zedeler Karin, Rasmussen Birgitte Bruun, Carstensen Bendix, Mouridsen Henning T., The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG), 10.1007/bf00666005
  36. Teschendorff Andrew E, Naderi Ali, Barbosa-Morais Nuno L, Pinder Sarah E, Ellis Ian O, Aparicio Sam, Brenton James D, Caldas Carlos, 10.1186/gb-2006-7-10-r101
  37. van Vliet Martin H, Reyal Fabien, Horlings Hugo M, van de Vijver Marc J, Reinders Marcel JT, Wessels Lodewyk FA, Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability, 10.1186/1471-2164-9-375
  38. Fan Cheng, Oh Daniel S., Wessels Lodewyk, Weigelt Britta, Nuyten Dimitry S.A., Nobel Andrew B., van't Veer Laura J., Perou Charles M., Concordance among Gene-Expression–Based Predictors for Breast Cancer, 10.1056/nejmoa052933
  39. Haibe-Kains Benjamin, Desmedt Christine, Piette Fanny, Buyse Marc, Cardoso Fatima, van't Veer Laura, Piccart Martine, Bontempi Gianluca, Sotiriou Christos, Comparison of prognostic gene expression signatures for breast cancer, 10.1186/1471-2164-9-394
  40. Kim Seon-Young, Effects of sample size on robustness and prediction accuracy of a prognostic gene signature, 10.1186/1471-2105-10-147
  41. Zhao Xi, Rødland Einar Andreas, Sørlie Therese, Naume Bjørn, Langerød Anita, Frigessi Arnoldo, Kristensen Vessela N., Børresen-Dale Anne-Lise, Lingjærde Ole Christian, Combining Gene Signatures Improves Prediction of Breast Cancer Survival, 10.1371/journal.pone.0017845
  42. Hornberger J., Alvarado M. D., Rebecca C., Gutierrez H. R., Yu T. M., Gradishar W. J., Clinical Validity/Utility, Change in Practice Patterns, and Economic Implications of Risk Stratifiers to Predict Outcomes for Early-Stage Breast Cancer: A Systematic Review, 10.1093/jnci/djs261
  43. Dowsett M., Nielsen T. O., A'Hern R., Bartlett J., Coombes R. C., Cuzick J., Ellis M., Henry N. L., Hugh J. C., Lively T., McShane L., Paik S., Penault-Llorca F., Prudkin L., Regan M., Salter J., Sotiriou C., Smith I. E., Viale G., Zujewski J. A., Hayes D. F., Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group, 10.1093/jnci/djr393
  44. Millar E K A, Graham P H, McNeil C M, Browne L, O'Toole S A, Boulghourjian A, Kearsley J H, Papadatos G, Delaney G, Fox C, Nasser E, Capp A, Sutherland R L, Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53, 10.1038/bjc.2011.228
  45. Tang Gong, Cuzick Jack, Costantino Joseph P., Dowsett Mitch, Forbes John F., Crager Michael, Mamounas Eleftherios P., Shak Steven, Wolmark Norman, Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor–Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors, 10.1200/jco.2011.35.3714
  46. Cuzick Jack, Dowsett Mitch, Pineda Silvia, Wale Christopher, Salter Janine, Quinn Emma, Zabaglo Lila, Mallon Elizabeth, Green Andrew R., Ellis Ian O., Howell Anthony, Buzdar Aman U., Forbes John F., Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer, 10.1200/jco.2010.31.2835
  47. Barton S, Zabaglo L, A'Hern R, Turner N, Ferguson T, O'Neill S, Hills M, Smith I, Dowsett M, Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer, 10.1038/bjc.2012.166